Bone Marrow Failure Flashcards

1
Q

What is pancytopenia

A

it includes low rbc wbc and plts.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is bone marrow failure definition

A

pancytopenia due to failulre of bm to produce blood cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what are thee symptoms of bm failure

A

anemia, difficulty breathing, chest pain and fatigue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what are symtpoms of leukopenia/neutropenia

A

fever, infxn, mouth sores

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what are symtpoms of thrombocytopenia

A

bleeding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what are things that may lead to hypercellular marrow?

A

hematologic malignancies, leukemias,myeloma, lymphoma, carcinoma, storage disoreders, myelodysplastic syndromes, b12 or folate deficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what are things leadings to hypocellular marrow

A

congential (fanconis anemia)

acquired (idiopathic, myelodysplastic syndrome, drugs radiation,viruses)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what is aplastic anemia?

A

sever, life-threatening syndrome in which production of rbcs, wbcs and plts has failed. may occur in all age groups
charaxterized by peripheral pancytopenia and accompanied by a hypocellular bone marrow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what is the pathophysiology of aplastic anemia?

A

primary defect is reduction in or depletion of hematopoeitic precursor stem cells. this is what leads to peripheral pancytopenia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what three problems can lead to aplastic anemia in terms of pathways?

A

failure of self-renewal, proliferation or differentiation, or no cytokines and gf from environment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what is fanconi’s anemia

A

usually symptomatic around age 5 and has progressive bm hypoplasia. congenital defects such as skin hyperpigmentation and small stature are also seen in affected individuals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what is familial aplastic anemia

A

a subset of fanconi’s in which congenital defects are absent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what are viral infxns that can lead to aplastic anemia?

A

mononucleosis, infxs hepatitis, parvovirus, and cytomegalovirus infxns as well as tuberculosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what are lab findings of aplastic anemia?

A

severe pancytopenia with relative lymphocytosis, normochromic rbcs, mild to moderate anisocytosis and poikilocytosis, decreased retic count, hypocellular bone marrow with more than 70% yellow marrow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

how do you treat aplastic anemia?

A

withdrawal of offending agent
transfusions, antibiotics
immunosuppressive regimns
hsct

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what is pure red cell aplasia?

A

pure red cell aplasia is characterized by a selective decrease in erythroid precursor cells in bm. wbcs and plts are unaffected.

17
Q

what are myelodysplastic syndromes?

A

primary, neopalstic stem cell disorders that ten to terminate in acute leukemia. normally bm is normocellualar or hyperceull. with evidnce of qualitiative abnormaliites in one or more cell lines resutling in ineffective erythropoiesis

18
Q

what is a common histo sighting in mds?

A

ringed sideroblasts

19
Q

When do myelodysplastic syndromes become Acute Myelogenous Leukemia?

A

when the blast count rises about 20% for who and 30% for fba

20
Q

What are the goals of treatment of mds?

A

control symptoms, improve quality of life, improve overall survival, and decrease progression to acute myelogenous leukemia

21
Q

what is the mainstay of treatment of myelodysplastic syndromes?

A

supportive care with blood products and hematopoeitic growth factors (epo)

22
Q

what chemotherapy agent is used with myelodysplastic syndromes?

A

methylating agent 5-azacytidine and decitabine (they decrease the need for blood transfusions and retard the progression of mds to aml and increase survival)

23
Q

what was approved in 2005 for the treatment of mds with the 5q syndrome?

A

lenalidomide

24
Q

what in general can be down for mds patients that are younger and more severely affected patients?

A

hsct

25
Q

What is autologous stem cell transplant?

A

It is when stem cells are collected from the patient, stored in a freezer, and reused within that patient later following a high dose of chemotherapy.

26
Q

what are the advantages of allogeneic stem cell transplant?

A

they can be used when recipient’s bone marrow fails such as in aplastic anemia and myelodysplastic syndrome. when recipient has a certain disease such as leukemia and lymphoma, the donor cells can attack these tumor cells via graft versus disease effect to prevent relapse of the tumor.

27
Q

What are disadvantages of hsct?

A

higher risk of chemotherapy related complications
higher risk of infxn compared to auto sct
risk of gvhd

28
Q

what is myeloablative hsct?

A

bm is ablated with dose-levels of chemo that cause minimal injury to other tissues. the chemo or irradiation given immediately prior to a translant is called the condition of preparative regimen, prior to infusion of hsc.

29
Q

what is non-myeloablative hsct?

A

newer tx approach using lowerdoses of chemotherapy and radiation which are too low to eradicate all of the bm of a recipient. goal is to prevent donor cells from being rejected by recipient. also called reduced intensity allogeneic transplant.

30
Q

why would you use non-myeloablative hsct?

A
  1. it is less intense, so there are less complications associated with typical chemotherapy.
  2. leaving some of your original stem cells can lead to the beneficial effect of graft vs disease.
31
Q

what are the complications of infxns due to hsct?

A

bm transplant usually requires destruction of your own cells, leading to low numbers of immune cells to fight infxn
immunosuppressive agents employed in allogeneic transplants for the prevention of tx of gvhd further increase risk of infxn
patient must be revaccinated because they lose their acquired immunity.

32
Q

what are additional complications due to hsct?

A

veno-occlusive disease
mucositis
gvhd (acute and chronic)

33
Q

how do you treat gvhd?

A

prevent of acute with cyclosporine and methotrexate to supress immune response
tx with high dose of steroids

34
Q

when is graft versus tumor disease beneficial?

A

when it’s a slowly progressing tumor, chronic leukemia, low-grade lymphoma, and some cases multiple myeloma. less effectve in rapidly growing acute leukemias.